In just two days, the second edition of the London Biotechnology Show (LBS) returns to ExCeL London on 18–19 June, bringing together one of the most influential gatherings in the global biotechnology calendar. The event promises cutting-edge science, transformative innovation, and forward-thinking leadership

This year’s conference programme is rich and diverse, covering transformative areas such as gene editing, regenerative medicine, digital health, medical devices, bioinformatics, biotechnology in agriculture, and more. Beyond addressing emerging biotech trends, the agenda is designed to deliver practical insights and strategies for real-world impact.

Among the keynote speakers and panelists, delivering their deep insights on these topics, are some of the sector’s most recognisable figures, including:

● Howard Dawber, Deputy Mayor of London for Business and Growth
● Claire Kerridge and Kingyin Lee from the MHRA
● Professor Sir Mark Caulfield, Vice Principal for Health, Queen Mary University of
London
● Professor Chris Johnson, Chief Scientific Advisor, Department for Science,
Innovation and Technology (DSIT)
● Dr. Samana Brannigan, Head of Health Technologies, Innovate UK
● Robert Vries, CEO of HUB Organoids, MERCK
● Dr. Nicole Mather, Health & Life Sciences Leader, IBM
● Thomas Balkizas, Senior Director Life Sciences, Microsoft
● Jimmy Toulas, World and Commercial Data Director, Pfizer
● Jakob E. Larsen, Target Discovery Project Director, Novo Nordisk
● Dr. Bryn Roberts, Global Head of Data, Analytics & Research, Roche

What truly sets this edition apart, however, is the scale and depth of the exhibition showcase, which features nearly 100 participating companies. Categories span a broad spectrum of solutions, including:

● Laboratory equipment
● Biotech and life sciences R&D
● Health tech and artificial intelligence
● Consulting and compliance services
● Advanced manufacturing and logistics
● A dedicated startup and innovation zone that aims to spotlight fresh talent and
disruptive technologies

Confirmed exhibitors include leading names such as Discovery Park, Thistle Scientific, G&L Scientific, Haier Biomedical UK ltd, Ellab, Mathys & Squire, ACRO Biosystems, Cool Repair system, Homogenising Systems Ltd, Merck, nNano, ZAGENO Inc., UPG International LLC, Genizer LLC, Thermo Fisher Scientific, BIORCE, Persistent Systems, Heart Biotech, Symbiotica Therapeutics, GutSee Health, Apeikon Therapeutics among others. The showcase offers attendees an unmissable opportunity to engage with the latest biotech tools, services, and partnerships that are pushing the boundaries of innovation.

With just two days to go, the momentum is undeniable. Whether you’re a researcher, entrepreneur, policymaker, or investor, the London Biotechnology Show 2025 is shaping up to be a must-attend event for anyone curious about the future of biotech.